Departments of Neurology and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY (F.M.E.).
Neurology Service, VA Bronx Healthcare System, NY (F.M.E.).
Stroke. 2023 Mar;54(3):648-660. doi: 10.1161/STROKEAHA.122.038265. Epub 2023 Feb 27.
Cerebral small vessel disease (CSVD) has emerged as a common factor driving age-dependent diseases, including stroke and dementia. CSVD-related dementia will affect a growing fraction of the aging population, requiring improved recognition, understanding, and treatments. This review describes evolving criteria and imaging biomarkers for the diagnosis of CSVD-related dementia. We describe diagnostic challenges, particularly in the context of mixed pathologies and the absence of highly effective biomarkers for CSVD-related dementia. We review evidence regarding CSVD as a risk factor for developing neurodegenerative disease and potential mechanisms by which CSVD leads to progressive brain injury. Finally, we summarize recent studies on the effects of major classes of cardiovascular medicines relevant to CSVD-related cognitive impairment. Although many key questions remain, the increased attention to CSVD has resulted in a sharper vision for what will be needed to meet the upcoming challenges imposed by this disease.
脑小血管病(CSVD)已成为驱动与年龄相关疾病(包括中风和痴呆)的常见因素。CSVD 相关痴呆将影响越来越多的老年人群,这需要提高对其的识别、理解和治疗水平。本综述描述了用于诊断 CSVD 相关痴呆的不断发展的标准和影像学生物标志物。我们描述了诊断方面的挑战,特别是在混合病理和缺乏针对 CSVD 相关痴呆的高度有效生物标志物的情况下。我们综述了 CSVD 作为神经退行性疾病风险因素的证据,以及 CSVD 导致进行性脑损伤的潜在机制。最后,我们总结了与 CSVD 相关认知障碍相关的主要类别的心血管药物的近期研究。尽管仍有许多关键问题尚未解决,但对 CSVD 的关注度增加,使人们更加清楚地认识到需要采取哪些措施来应对这种疾病带来的挑战。